Which of the following antipsychotics can be given to patients with QT interval issues?

Lurasidone is recognized for its relatively lower risk of causing significant QT interval prolongation compared to many other antipsychotics. In clinical practice, it's often preferred for patients who have existing QT interval concerns, as it has been shown to have a more favorable cardiac safety profile. This makes it a suitable option for individuals at risk for arrhythmias or other cardiovascular issues associated with extended QT intervals.

Other antipsychotics listed can carry higher risks of QT prolongation. Clozapine can lead to cardiovascular side effects and is not recommended for those with known QT issues. Fluphenazine, being a typical antipsychotic, also has potential cardiac effects that warrant caution. Olanzapine, while widely used, has been linked to some degree of QT prolongation as well. Due to these considerations, lurasidone stands out as a safer choice for managing psychosis in patients with pre-existing QT interval issues.